HighTower Advisors’s Amgen AMGN Stock Holding History

HighTower Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$2.77K	–	3761
2025 Q1	$2.77K	Sell	1,000 -600	-38%	-$177K	﹤0.01%	3613
2024 Q4	$6.4K	Buy	+1,600	New	+$475K	﹤0.01%	3615
2022 Q2	–	Sell	-1	Closed	-$11K	–	3231
2022 Q1	$11K	Buy	+1	New	+$230	﹤0.01%	3207
2014 Q3	–	Sell	-11,900	Closed	-$37K	–	1537
2014 Q2	$37K	Hold	11,900	–	–	﹤0.01%	1524
2014 Q1	$89K	Hold	11,900	–	–	﹤0.01%	1388
2013 Q4	$65K	Buy	11,900 +400	+3%	+$45.5K	﹤0.01%	1404
2013 Q3	$54K	Buy	+11,500	New	+$1.25M	﹤0.01%	1242

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HighTower Advisors's AMGN Position: Q2 2026 in Review

HighTower Advisors reduced its Amgen (AMGN) stake by 0.5% in Q2 2026, selling an estimated $1.39M and leaving 816,257 shares worth $296M. The position accounts for 0.28% of the portfolio, ranked #71.

HighTower Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

HighTower Advisors held 816,257 shares of Amgen worth $296M as of Q2 2026.
HighTower Advisors sold 4,063 Amgen shares in Q2 2026, an estimated $1.39M.
Amgen made up 0.28% of HighTower Advisors's portfolio in Q2 2026, its #71 holding.
HighTower Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.